These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34514027)

  • 21. The Engraftment of Lentiviral Vector-Transduced Human CD34+ Cells into Humanized Mice.
    Kim YS; Wielgosz M; Ryu B
    Methods Mol Biol; 2019; 2005():91-100. PubMed ID: 31175648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene therapy of Diamond Blackfan anemia CD34(+) cells leads to improved erythroid development and engraftment following transplantation.
    Flygare J; Olsson K; Richter J; Karlsson S
    Exp Hematol; 2008 Nov; 36(11):1428-35. PubMed ID: 18715690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [From gene to disease; hereditary non-spherocytic hemolytic anemia caused by pyruvate kinase deficiency].
    de Vooght KM; van Wijk R; Nieuwenhuis HK; Ploos van Amstel JK; Rijksen G; van Solinge WW
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1828-31. PubMed ID: 12382367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Appraisal of patient-reported outcome measures in analogous diseases and recommendations for use in phase II and III clinical trials of pyruvate kinase deficiency.
    Salek MS; Ionova T; Johns JR; Oliva EN
    Qual Life Res; 2019 Feb; 28(2):399-410. PubMed ID: 30456713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector.
    Gao Z; Golob J; Tanavde VM; Civin CI; Hawley RG; Cheng L
    Stem Cells; 2001; 19(3):247-59. PubMed ID: 11359950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-Efficiency Lentiviral Transduction of Human CD34
    Uchida N; Nassehi T; Drysdale CM; Gamer J; Yapundich M; Demirci S; Haro-Mora JJ; Leonard A; Hsieh MM; Tisdale JF
    Mol Ther Methods Clin Dev; 2019 Jun; 13():187-196. PubMed ID: 30788387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Sri Lankan girl with a new genetic variant in the PKLR gene causing pyruvate kinase deficiency: a case report.
    Sivashangar A; Gooneratne L; Clark B; Rees D; Jayasinghe S; Laas C
    J Med Case Rep; 2021 Jul; 15(1):374. PubMed ID: 34311792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Six novel variants in the PKLR gene associated with pyruvate kinase deficiency in Argentinian patients.
    Milanesio B; Pepe C; Defelipe LA; Eandi Eberle S; Avalos Gomez V; Chaves A; Albero A; Aguirre F; Fernandez D; Aizpurua L; Paula Dieuzeide M; Turjanski A; Bianchi P; Fermo E; Feliu-Torres A
    Clin Biochem; 2021 May; 91():26-30. PubMed ID: 33631127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lentiviral hematopoietic cell gene therapy for X-linked adrenoleukodystrophy.
    Cartier N; Hacein-Bey-Abina S; Bartholomae CC; Bougnères P; Schmidt M; Kalle CV; Fischer A; Cavazzana-Calvo M; Aubourg P
    Methods Enzymol; 2012; 507():187-98. PubMed ID: 22365775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison Study.
    Urbinati F; Campo Fernandez B; Masiuk KE; Poletti V; Hollis RP; Koziol C; Kaufman ML; Brown D; Mavilio F; Kohn DB
    Hum Gene Ther; 2018 Oct; 29(10):1153-1166. PubMed ID: 30198339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandin E
    Heffner GC; Bonner M; Christiansen L; Pierciey FJ; Campbell D; Smurnyy Y; Zhang W; Hamel A; Shaw S; Lewis G; Goss KA; Garijo O; Torbett BE; Horton H; Finer MH; Gregory PD; Veres G
    Mol Ther; 2018 Jan; 26(1):320-328. PubMed ID: 29102562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A New Variant of PKLR Gene Associated With Mild Hemolysis may be Responsible for the Misdiagnosis in Pyruvate Kinase Deficiency.
    Aydin Köker S; Oymak Y; Bianchi P; Gözmen S; Karapinar TH; Fermo E; Vergin RC
    J Pediatr Hematol Oncol; 2019 Jan; 41(1):e1-e2. PubMed ID: 30028822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concentrated RD114-pseudotyped MFGS-gp91phox vector achieves high levels of functional correction of the chronic granulomatous disease oxidase defect in NOD/SCID/beta -microglobulin-/- repopulating mobilized human peripheral blood CD34+ cells.
    Brenner S; Whiting-Theobald NL; Linton GF; Holmes KL; Anderson-Cohen M; Kelly PF; Vanin EF; Pilon AM; Bodine DM; Horwitz ME; Malech HL
    Blood; 2003 Oct; 102(8):2789-97. PubMed ID: 12829597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expanded circulating hematopoietic stem/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis.
    Capo V; Penna S; Merelli I; Barcella M; Scala S; Basso-Ricci L; Draghici E; Palagano E; Zonari E; Desantis G; Uva P; Cusano R; Sergi Sergi L; Crisafulli L; Moshous D; Stepensky P; Drabko K; Kaya Z; Unal E; Gezdirici A; Menna G; Serafini M; Aiuti A; Locatelli SL; Carlo-Stella C; Schulz AS; Ficara F; Sobacchi C; Gentner B; Villa A
    Haematologica; 2021 Jan; 106(1):74-86. PubMed ID: 31949009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Staurosporine Increases Lentiviral Vector Transduction Efficiency of Human Hematopoietic Stem and Progenitor Cells.
    Lewis G; Christiansen L; McKenzie J; Luo M; Pasackow E; Smurnyy Y; Harrington S; Gregory P; Veres G; Negre O; Bonner M
    Mol Ther Methods Clin Dev; 2018 Jun; 9():313-322. PubMed ID: 30038935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hematopoietic Stem Cell-Targeted Neonatal Gene Therapy with a Clinically Applicable Lentiviral Vector Corrects Osteopetrosis in
    Löfvall H; Rothe M; Schambach A; Henriksen K; Richter J; Moscatelli I
    Hum Gene Ther; 2019 Nov; 30(11):1395-1404. PubMed ID: 31179768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Red Blood Cell Metabolism in Pyruvate Kinase Deficient Patients.
    Roy MK; Cendali F; Ooyama G; Gamboni F; Morton H; D'Alessandro A
    Front Physiol; 2021; 12():735543. PubMed ID: 34744776
    [No Abstract]   [Full Text] [Related]  

  • 38. Lentiviral-Mediated Gene Therapy in Fanconi Anemia-A Mice Reveals Long-Term Engraftment and Continuous Turnover of Corrected HSCs.
    Molina-Estevez FJ; Nowrouzi A; Lozano ML; Galy A; Charrier S; von Kalle C; Guenechea G; Bueren JA; Schmidt M
    Curr Gene Ther; 2015; 15(6):550-62. PubMed ID: 26415575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease.
    Poletti V; Urbinati F; Charrier S; Corre G; Hollis RP; Campo Fernandez B; Martin S; Rothe M; Schambach A; Kohn DB; Mavilio F
    Mol Ther Methods Clin Dev; 2018 Dec; 11():167-179. PubMed ID: 30533448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyruvate Kinase Deficiency: Current Challenges and Future Prospects.
    Fattizzo B; Cavallaro F; Marcello APML; Vercellati C; Barcellini W
    J Blood Med; 2022; 13():461-471. PubMed ID: 36072510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.